HIMS Today - Jul 10: Stock Takes a Hit
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
HIMS Today - Jul 10: Stock Takes a Hit
-
ナレーター：
-
著者：
So, here’s the scoop. HIMS started off a bit shaky and just couldn’t catch a break. The volume was pretty low compared to usual, which usually isn’t a great sign. I mean, when people aren’t trading as much, it often means they’re not feeling too confident.
Now, why the drop? A couple of things played into it. First off, Truist came out and said they’re sticking with a “Hold” rating on HIMS, throwing a $23 price target out there. With all the buzz around GLP-1 drugs, there’s some concern about how that’ll affect HIMS’s business model. Plus, there were some mixed signals from Citi, suggesting that while there’s a “big caveat” in Amazon’s GLP-1 push, it might limit risks for HIMS. But still, uncertainty is never good for stock prices, you know?
Also, there was talk about HIMS bulking up their debt raise to $350 million for a buyout, and that usually makes investors a bit jittery. It’s like, “Why are you raising that much debt?” People want to see companies grow without piling on the loans. And with all this chatter about valuation and whether it's already too rich, it just added to the overall anxiety.
Now, on the horizon, keep an eye out for any updates regarding their AI push and how that’s going to roll out. That could be a game-changer if they play their cards right.
So, yeah, it was a tough day for HIMS. But that’s the market for you—up and down like a roller coaster. Just remember, this recap is for your info and entertainment, not financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません